Emmalin Age: 7.5

Emmalin Age: 7.5

Tuesday, August 21, 2012

The Story of CDKL5

This is another great link that explains a lot!!  (Click below to check it out)


                                                                The Story of CDKL5

Research Articles on CDKL5


CDKL5 Research Times (produced by the International Foundation for CDKL5 Research)

August 2011

 

Research Articles:


Recurrent mutations in the CDKL5 gene: Genotype-phenotype relationships. American Journal of Medical Genetics 2012. Link to abstract
This study from France looks at whether there is a relationship between mutation and severity of phenotype. A total of 26 CDKL5 mutations were identified in 358 unrelated females who had been referred with encephalopathy and early seizures. Most of these mutations were unique but 8 were recurrent mutations that had previously been described in other studies (including studies published by this group). By studying females with recurrent mutations in both this study and those from previous studies, the authors have drawn some conclusions about the relationship between site of mutation and severity of phenotype. They looked at mutations occurring in 3 particular areas of the CDKL5 protein, the ATP binding site and the ST kinase active site, both of which lie in the catalytic or kinase domain, and the large C-terminal domain of the protein. They found that mutations affecting the ST kinase site and the C-terminal domain produced more severe phenotypes (refractory epilepsy, limited hand skills, non-walkers) than mutations affecting the ATP binding site. The mutations identified were missense and truncating mutations in the ST kinase segment and frameshift mutations in the C-terminal domain. In the ATP binding site, the recurrent mutations were all missense mutations at amino acid position 40, and when compared to girls with other CDKL5 mutations (presumably in this same area), those with this particular mutation (which is termed p.Ala40Val) tended to present with better hand use and better ability to walk. They also looked at whether X-inactivation (see The story of CDKL5) might also have an effect on phenotype but were unable to draw any useful conclusion.
Note - Overall I found this quite compelling reading really and it certainly builds on previous studies that have suggested links between position of mutation and phenotype. I was a little unsure about the exact number of girls in this study who actually had CDKL5, but overall I think it is a good and useful study. The fact that certain mutations at the C-terminal of the protein (which is well away from the kinase domain) are also associated with more severe phenotypes presumably suggests something about the 3-D structure of the CDKL5 protein in terms of how the C-terminal interacts with the kinase domain. There is a suggestion that part of the C-terminal might stabilise the protein against degradation and mutations here might therefore accelerate degradation -a view perhaps supported by the study below regarding a novel transcript. Who knows!
Variant of Rett Syndrome and CDKL5 gene: Clinical and autonomic description of 10 cases. Neuropediatrics 2012. Link to abstract

This study from Italy describes features in 10 girls, 8 from Italy and 2 from Sweden, aged between 2 and 13 years. All had established CDKL5 mutations (4 missense, 3 frameshift, 1 nonsense and 2 deletions). Early-onset epilepsy was the predominant feature with 9 developing seizures by the 4th month of life and one at 6 months. Speech was absent in all 10 girls, while 8 had some sort of disturbance of their vision. All 10 had experienced disturbances in their sleep patterns during the first 4 months of life and 7 continued to do so at the time of the review. The autonomic aspect of the study focussed on breathing patterns. There are 4 recognised disorders of breathing in Rett Syndrome. Forceful breathing patterns were noted in 8 of the girls with CDKL5 while the remaining 2 girls exhibited the apneustic type.

Note - A study which again reinforces many of the features we are coming to recognise as part of the CDKL5 spectrum. The description of the breathing patterns is interesting as I have not encountered this in any other studies I have read (I may have missed something!). They also discuss other autonomic dysfunction such as cold hands and feet, all of which we recognise in Ellie.
A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain. Human Genetics 2012. Link to abstrac

The molecular characterisation of the CDKL5 protein is still largely unknown. However, previous research has identified 3 different variants of the CDKL5 protein. This paper describes the theoretical existence of a 4th variant which the authors then go on to show not only exists, but is likely to be the predominant form expressed in the human brain. Although the CDKL5 gene contains 21 coding exons, this novel variant is shorter, only incorporating amino acids coded in exons up to 18. They conclude that this novel variant is likely to be of primary pathogenic importance in CDKL5-related conditions.
Note - This is quite a technical-based paper and took me several malts to get through!! It is estimated that the human body is made up of over 100,000 different proteins yet only contains some 25 - 30,000 genes. This means that on average, one gene may code for perhaps 4 - 5 proteins, and this seems to be the case with CDKL5. The authors of this paper are suggesting that they may have identified one particular form of the CDKL5 protein which is slightly shorter in length, amino acids coded in exons 19 - 21 are not incorporated, and may be the relevant form of the protein in CDKL5-related conditions. This therefore needs to be considered when screening children who present with features of CDKL5.

CDKL5 in different atypical Rett syndrome variants: Description of the first eight cases from Spain. Journal of Pediatric Epilepsy 2012. Link to text

This study is from the Saint Joan de Deu Children's Hospital in Barcelona. Over a 26 year period, 408 patients were diagnosed with classical or variant Retts. There were 258 children identified who had mutations of the MECP2 gene. Of the remaining 150 without a genetic diagnosis, testing for CDKL5 mutations was offered to 53 girls and 9 boys who had either early epilepsy, polymorphic seizures or drug-resistant seizures. They found 8 (15%) of the girls, but none of the boys, had novel pathogenic mutations of the CDKL5 gene. There were variations in the phenotypes of the 8 children, compared to those described in other studies and which have been taken to be characteristic of CDKL5. For instance, the 3 stages of epilepsy as described by Bahi-Buisson were not observed, with only 4 children developing seizures within the first few months of life. There were 3 who developed their seizures at 11 months, 2 and 3 years of age and 1 who did not appear to have developed seizures at all. There were 2 children who regained some speech having previously lost it. The authors report some association between the severity of the phenotype and the location of the mutation with the more severely affected having a mutation at the proximal region of the gene. The authors conclude that testing for CDKL5 must be mandatory in patients with Rett syndrome and early epilepsy, in those with epileptic encephalopathy with onset in the first year of life as well as in those with classical or variant Retts without an identifiable MECP2 gene mutation.

Note - This article clearly throws a slight spanner in the works in that some variation is introduced into what, up to now, have been considered fairy constant characteristics of children with CDKL5, particularly in relation to the presence of early seizures. It therefore at least raises the possibility that the spectrum of CDKL5 phenotypes may be broader than first thought. This issue of the Journal also has an editorial by Jeffrey Neul from the Texas Children's Hospital, which includes a short review of this article. He concludes that perhaps CDKL5 should now be recognised as a distinct clinical disorder with specific unique characteristics rather than as a variant of Rett syndrome, and that not to do so might be a disservice to both clinical medicine and to those with the condition. Bravo!

Further Note - A subsequent Letter to the Editor regarding this article has pointed out that one of the described mutations, which affects almost the very end of the C-terminal domain, may only have "minimal" clinical effect. This is because a mutation at this site (which is in exon 20) affects that part of the CDKL5 gene which is not used to make the particular form of the protein that may be relevant in CDKL5 disorders (see last paper above). This may explain some of the variation in presentation described in the paper, in that the individual with this mutation may not in fact have a CDKL5 related disorder. The plot thickens!!!

Historic, clinical and prognostic features of epileptic encephalopathies caused by CDKL5 mutations. Paediatric Neurology 2012. Link to abstract.

This is a retrospective study from the Mayo Clinic, looking at the clinical features and treatment of seizures in 6 children (4 girls, 2 boys) with CDKL5. The onset of seizures ranged from 1 to 3 months of age. Particular features are discussed including dysphagia (difficulty swallowing) and cortical visual impairment. It is also noted that the 2 males in the group appeared less affected by certain features than the females. No particular treatment eliminated seizures, but topiramate, vigabatrin and the ketogenic diet were the most helpful at reducing their frequency.

Note - This is a study of a small number of children with a relatively short follow-up period, less than 3 years in 2 children and no more than a year in the other 4. The children studied are all young (eldest less than 3 years of age at review). The prognostic features referred to in the title seem to be the presence of the CDKL5 mutation itself and the resultant early-onset of seizures. Vagal Nerve Stimulation (VNS) does not appear to have been used as a treatment option, possibly because of the age of the children involved, although a recent study has suggested that VNS is a safe and effective treatment for resistant epilepsy in young children. The authors of the above study rightly conclude that more research is needed

Adult Phenotypes in Angelman- and Rett- Like Syndromes. Molecular Syndromology. Published online: January 13 2012. Link to abstract.

This paper looks at the evolution of the clinical characteristics (phenotype) in adults with various syndromes, and includes a female who was diagnosed with a splice site mutation in intron 7 of CDKL5 at the age of 47. She had developed seizures after 6 months and a subsequent delay in psychomotor development. Her motor development had only been mildly delayed, but she hadn't learned to speak and she had profound intellectual disability. Her seizures had persisted despite multiple drug treatments. She was small, being at the lower end of centile charts and displayed a number of facial characteristics including prominent cheekbones, mild prognathism, deep-set eyes and blepharochalasis. A number of other characteristics are also described. The authors state that this is the oldest reported patient with a CDKL5 mutation. They also then review adult phenotypes reported in other published studies, which, with the adult in this study comprises a group of 10 adults with an age range from 18 to 47 years. From this review they surmise that apart from difficulty with seizure control, adults with CDKL5 may also have medical problems such as secondary scoliosis, contractures, feeding difficulties and airway infections.

Note - It is probably with some caution that we should apply the findings in this relatively small group of adults to every child now growing up with CDKL5, because, as many of us are aware, although our children share many characteristics, they also display variable levels of function and development. Furthermore, the fact that CDKL5 is now recognised as a separate condition may improve their longer-term outcome through earlier diagnosis and subsequent improvement in treatment and care. Although factors that may influence their longer term development are still to be determined, we are sure to learn more as longitudinal studies continue.

Genes of Early-Onset Epileptic Encephalopathies: From Genotype to Phenotype. Paediatric Neurology 2012. Link to text.

This is a review of genetic disorders associated with early-onset epileptic encephalopathies and the associated phenotypes, including CDKL5. The authors report that to-date 53 pathologic mutations of CDKL5 have been reported consisting of 12 missense, 4 nonsense, 8 splice-site, 22 deletions and 7 frameshift mutations. They state that no correlation has been established between the site of mutation and clinical severity and then go on to discuss a more severe epileptic encephalopathy as described by Bahi-Buisson et al. They review the 3 stages of epilepsy in CDKL5 as described by Bahi-Buisson et al and the EEG findings as described in studies by Pintaudi et al and Melani et al.

Note - A good review article although a lot of information to digest. There also seems to be some ambiguity here about what is known so far about the site of mutation and the severity of the phenotype. This paper states that there is no correlation between severity and site of mutation (giving references), but then refers to the study by Bahi-Buisson which suggests that there may be. This is the ambiguity I can't quite sort out - the CDKL5 gene has been designated Online Mendelian Inheritance in Man OMIM® no. *300203 (the * indicates that this designation applies to the gene and its mutations) and it is to this designation that there is said to be no relation between site and severity. However, there is also another designation, OMIM® #300672 which is a descriptive designation for a phenotype (indicated by the #) and refers to a more severe form of epileptic encephalopathy also associated with CDKL5 -and which according to the study by Bahi-Busson has a phenotype that may well be related to the site of mutation. If the genetic basis for both designations lies within the CDKL5 gene, why have 2 designations or are they being considered as distinct entities? There must be a straight-forward answer here but for now this remains slightly confusing (to me at least) and although I contacted OMIM® to clarify this, I am not sure that I am any the wiser for the response (I would be grateful for clarification from anybody!!) Clearly, the bottom line is that more children with CDKL5 mutations need to be studied to understand the relationship between site of mutation and severity of phenotype, and ultimately, severity will probably depend on several factors, and not just the site of mutation.

A survey of parents of children with cortical or cerebral visual impairment. Journal of Visual Impairment and Blindness 2010. Link to text.

This study summarises the results of a survey of 80 parents who have children with Cortical or Cerebral Visual Impairment (CVI). The various aetiologies (causes) are reviewed along with rehabilitation and intervention strategies. The most effective rehabilitation is said to be that which involves parents and other family members. Motion, particularly of a coloured object is the most important factor in improving the visual response. The survey also looks at 3 issues - how do parent's receive the diagnosis of CVI, what educational support do children with CVI receive, and what do parents of children with CVI feel about the support they and their children receive.

Note - This article has been written by parents of children with Cortical Visual Impairment (CVI) . This is not something that we read so much about in CDKL5 articles, as the focus tends to be on seizures, developmental delay and mobility. However, children with CDKL5 certainly do suffer from CVI and although this article covers a broad spectrum of issues, many are relevant to us which I think is very helpful.

Gastrointestinal Disorders in Children with Neurodevelopmental Disabilities.

Developmental Disabilities Research Reviews 2008. Link to abstract.

As the title suggests, this article reviews the various gastrointestinal problems that children with neurodevelopmental disabilities can suffer. It systematically describes problems from the mouth and swallowing, through to the lower bowel and constipation. Underlying causes are discussed and the various treatment options reviewed. The author points out how difficulties with eating may be confused with behavioural food avoidance or aversion, and that abdominal discomfort can present as chronic irritability, crying or dystonic (involuntary twisting or repetitive) movements of the face and neck. More than 80% of children with gastro-oesophagel reflux will have recurrent vomiting. Constipation is discussed and defined as opening of bowels less frequently than 3 times per week or the regular need for laxatives. Constipation is a common problem in children with disabilities and can go unrecognised for years. Treatment requires a consistent approach by willing parents and carers.

Note - Although this review tends to refer frequently to children with cerebral palsy, many of the problems discussed will apply to children with CDKL5. I have highlighted 2 particular issues that are discussed, gastro-oesophageal reflux and constipation, as these will be familiar to most of us. There is one particular telling line in the discussion about gastro-oesophagel reflux, which says "It is ironic that the learning deficit that usually accompanies neurological impairment also impairs the ability of the individual to communicate the main symptom... which is pain." A good and very useful review article - I have a full copy if anyone would like to read it

Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Developmental Medicine & Child Neurology 2004. Link to text.

Sleep is thought to be a learned neurological process that develops in response to cues from the environment. This is a process that we all go through, but which is impaired in children with neurodevelopmental problems. As a result they can retain their fragmented "baby" pattern of sleeping, potentially throughout their life. Circadian rhythm sleep disorders (CRSD) occur when there is a dissociation between sleep-wake behaviour and the environment. Parents should promote the sleep learning process through "highly regulated strict sleep hygiene". Melatonin is produced by the pineal gland in the brain, and although previous research has established that it can induce and maintain sleep, it's exact mechanism of action remains unclear. It does not promote sleep in the same way as a hypnotic (sleeping tablet) does, but may act by inhibiting neuronal excitability in the central nervous system. Exposure to light tends to decrease melatonin secretion while darkness promotes it. CRSD's tend to be associated with disturbance in melatonin secretion. There are also non-circadian rhythm sleep disorders due to pain from such things as reflux or orthopaedic problems, or from nocturnal seizures or related drug treatment. In the treatment of CRSD it is important to choose the correct melatonin formulation depending of the particular sleep disorder. Discontinuation for a few days is also recommended as children can acquire normal sleep patterns over time. Some studies suggest that children with neurodevelopmental disabilities, who have CRSD can show a 70-90% quick response. However, not all children respond equally and there may be some with certain conditions who may not benefit. No major side-effects of melatonin have been reported in paediatric studies.

Note - This review contains a lot of information about sleep disorders and the role of melatonin. One of the authors published the original study on the role of melatonin in sleep disorders, and so the enthusiasm for melatonin is understandable. They do state that much of the skepticism regarding melatonin was based on lack of quality control, unsubstantiated benefit claims, misconceptions about the action of melatonin and oversimplification about the relationship between melatonin and CRSD's. Perhaps the most relevant points for parents and carers are made in the first few paragraphs where they state that the majority of children with neurodevelopmental disabilities are said to have long-standing sleep disorders, and that the management is often neglected due to the inadequate training of doctors in these problems.











A Link To Help Explain the CDKL5 Genetic Mutations......

Here is another link that I thought was great about expalining the CDKL5 Genetic Mutation: (Click Below)

                                                                              Genetic Mutations...

A Link To Help Explain The Molecular Biology of CDKL5......


I just ran across this and thought it was interesting.  It's SO hard to understand everything that is involved with the CDKL5 gene deficiency and thought that this might help a little for those of you trying to understand a little more.  (Click Below):

                                                       The molecular biology of CDKL5......

Monday, August 20, 2012

Our 2012 Journey of Hope Benefit Video

Click on the link below to check out our new video that we had made for our benefit this past Saturday.  It's a video that talks about Emmalin's journey so far with the CDKL5 gene deficiency.  It is the same song that Jarrad and I wrote/sang (just like last time) but this time Jarrad changed around some of the music.  Enjoy :)

                                                    2012 Journey of Hope Benefit Video

Some pictures of the 2012 Benefit at Cartoons

Thank you to EVERY SINGLE PERSON that helped in ANY way to make our benefit a success!!  Jarrad and I are SO gratful for each and every one of you!! I'm going to start posting so pictures from that night, but there are a lot of them, so it's going to take me a little bit to get them all loaded on here.

As far as Emmalin goes, that day/night she did AMAZING!!  Jaci Velasquez took the time to actually talk with Emmalin, and Emmalin LOVED it!  I have never seen Emmalin pay attention to someone for that long.  Also, Emmalin wouldn't let go of Jaci's hand, she just kept squeezing it tighter and tighter.  Emmalin even talked back to her  a couple of times (in Emmalin's own way)!  This exchange between Jaci and Emmalin was by far, my FAVORITE moment of the night!  It was so special and something I will NEVER forget!!

Emmalin and Jaci Velasquez



Emmalin talking with Jaci

Emmalin and Uncle Corey


Emmalin with her pretty headband that Jaci gave her :)

These are the 2 girls that put the benefit together. 
My cousin Marin and my sister Jessica
(Aunt Jessica as Emmalin calls her)

Emmalin and Grandma Ruth


Emmalin with Mommy and Daddy

Emmalin with her speech therapist and friend Mrs. Lori :)

Emmalin with her Mommy, Daddy, Uncle Corey and Aunt Jessica


Emmalin, Jarrad (Daddy), Tiffany (Mommy) and Brad Cole (who was our auctioneer - and was AMAZING)

Emmalin with her Mommy taking a little break at the benefit.


Emmalin with her Grandma :)

Jaci Velasquez singing and Emmalin's Uncle Corey playing the guitar.

                                                       Jaci and Emmalin's Uncle Corey

Wednesday, August 8, 2012

No More Eating For Emmalin :(

                                                              
                                                             
                                                               Quality verses Quantity?

This is the question that we were asked Monday (August 6th) at Emmalin’s doctor’s appointment with her pulmonologist (at the St. Louis Children’s Hospital). When the doctors came in the room and started going over the results with us about the swallow study that Emmalin had done on May 20th, to say the least, it did not go the way I had hoped!
They said that the results weren’t good. Emmalin was aspirating :( They said that even though she wasn’t aspirating large amounts unless she was very fatigued in her mouth, even when she was not fatigued, she was still aspirating very small amounts. Although you would think that this would not be as big of a deal because it wasn’t normally large amounts, they explained that over time even small amounts (building up over days and years) can still hurt her quality of life down the road. Then the doctors said that we need to ask ourselves the question, which do we feel is more important, quality or quantity? Was it really worth feeding her the small quantities of food that she was eating knowing that it was going to hinder her quality of life in the long run?

Although they didn’t feel that she needed to have a surgery immediately to have a fundoplication done (because she hasn’t ever had any type of aspirating pneumonia), by stopping all food/fluids from going through her mouth would give her the best chance of not aspirating (therefore giving her the best quality of life). They also said that we wanted to touch back base in 6 months and at that time if we felt like she had got a lot stronger in her trunk and head control (because as strange as it sounds the stronger you are in these areas the more it can help you possibly not aspirate) and we felt she was possibly aspirating less, we could do another swallow study at that time. If the swallow study then showed that she was aspirating less, we could reevaluate the situation at that time.

I was having a hard time figuring out a way to explain what the fundoplication thing was all about and so I found this on the internet. I think it helps explain what the fundoplication surgery is:
             During fundoplication surgery, the upper curve of the stomach (the fundus) is wrapped around the esophagus and sewn into place so that the lower portion of the esophagus passes through a small tunnel of stomach muscle. This surgery strengthens the valve between the esophagus and stomach (lower esophageal sphincter), which stops acid from backing up into the esophagus as easily. This allows the esophagus to heal.

             This procedure can be done through the abdomen or the chest. The chest approach is often used if a person is overweight or has a short esophagus.

           This procedure is often done using a laparoscopic surgical technique. Outcomes of the laparoscopic technique are best when the surgery is done by a surgeon with experience using this procedure.

I guess I should back up and explain some things about when Emmalin got her feeding tube on July 5th of last year.

Last year when Emmalin got her feeding tube, although she had some acid reflex, it was not that bad. Emmalin had also not been aspirating in ANY way so there was no reason for her to have to have a fundoplication done when her feeding tube was being placed. In fact even after the feeding tube was placed, we were still able to feed Emmalin through her mouth, at least as much as she would tolerate. And although I knew that her mouth muscles were VERY weak (she was still only tolerating stage 2 baby food consistencies), I made it my priority from that day forward to try to make sure that we were doing everything in our power to help Emmalin get her mouth stronger. I even had a very small hope/dream that maybe even one day Emmalin would gain back so much strength in her mouth that she would be able eat ALL of her meals completely through her mouth and we would be able to get the feeding tube removed. So we made feeding therapy one of our main priorities, hoping to strengthen her muscles more and more as time went on. To show you how seriously we took it, we took Emmalin to 2 different feeding therapists a week up until April of this year when we had to stop because of her brain surgery.

And now, after all of that hard work…here we are, being given the option of “quality or quantity”. I have to say, my worst fear going into the appointment was that the doctor was going to say she had to have the fundoplication surgery, so I guess I should just be grateful that Emmalin doesn’t have to have that surgery!! But the thought of Emmalin NEVER eating through her mouth again, was SO hard for me to hear!! If fact, if I had to describe how I felt (and at this moment still feel) in three words, they would be: defeated, disappointed, and heartbroken!! I HATE CDKL5!!! And even though I still know that I have a TON to be grateful for, it still doesn’t make it easier when Emmalin loses a “typical” skill. In a weird way, when something as drastic as this happens, you mourn it (or at least this is how I seem to handle these situations). I know it sounds crazy, but when you fight SO hard to try to keep something going and then one day you find out, the battle is over, you lost and CDKL5 has won another round… it can be devastating!!

There are 2 other things that I have learned throughout the past year that are another part of the reason it has been SO increadibley hard to accept the fact that I can no longer feed Emmalin. One of the things was that when someone stops eating, there muscles in their mouth get A LOT weaker (Emmalin's are already REALLY weak to begin with)!! The second thing was that for people who are not very strong in the eating area (which is Emmalin); there is a chance that  when they are told they have to stop eating, their bodys can forget how to eat. If this happens, I was told that it is not like riding a bike, where the “motions” just come back to you. If Emmalin forgets how to eat, it will be lost forever, and the thought of this makes my heart ache with sadness! Have I mentioned how much I HATE CDKL5!!!!


I was talking with one of my dear friend, named Amy yesterday. Amy’s daughter, Lexi, also has CDKL5. Lexi is a lot older than Emmalin and although the girls are not EXACTLY alike, this is an area that Amy has already been through with Lexi. As I was talking with Amy, she was saying that it was also really hard for her when she was told by doctors that Lexi would never eat food through her mouth again. Amy shared a story with me that really helped me put Emmalin’s “not eating” in perspective and I would like to share it with you.

She said it was a couple of years after Lexi had stopped eating when she was talking to a doctor about the moment she was told Lexi would never eat again and how devastating it was!! The doctor’s response was very interesting! He said, “Was it devastating for you or Lexi?” She said, “What?” And he repeated the question “was it devastating for you or Lexi? Did Lexi even like eating?” Amy thought about it and said, “No, Lexi hated eating.” “So it was devastating for you, not Lexi”, the doctor said. The more Amy thought about it, she realized he was right. Lexi had always hated to eat, and actually looking back at it, eating was probably uncomfortable for her because of her aspiration issues. So the fact that she didn’t have to eat any more through her mouth was probably something that Lexi would have been really happy about.

I feel like I am in that same situation. I too feel like being told that Emmalin cannot eat through her mouth anymore, in some ways has been devastating. My heart aches because she will never have another taste of one of her birthday cakes and she’ll never have a favorite food, favorite candy, or even a favorite drink. But in reality, like Amy, this is all devastating for me NOT Emmalin. Also like Lexi, Emmalin doesn’t like to eat and I know that she is probably pumped about the fact that the doctor has just given her permission to NEVER have to do eat again!!

I’m SO grateful that Amy told me this story because it is a perspective that I probably would have never thought about. And in the “grand scheme of things”, I know that as big of a deal as this seems to me now, it’s really not a huge deal at all. Even though Emmalin can’t eat by mouth now, she still just as happy, healthy, beautiful, and amazing as ever!! I also am SO grateful that GOD is by my side as I accept this defeat and learn to cut my losses and move on to the next battle. It is because of HIM being with me ALWAYS that I know that it is all going to be ok because he already has it figured out!!

                                                                    God is Good!!